CancerGuide Diagnostics
Durham, NC
CEO: Dr. Myla Lai-Goldman
CancerGuide Diagnostics is focused on the development and commercialization of genomic-based clinical and pharmaceutical cancer tests and services, enabling physicians, patients and researchers to make individualized treatment or drug discovery decisions. The company's strategic partnership model lays the foundation for personalized oncology diagnostic discoveries.
